Singapore-based medical group opens first medical centre in Hong Kong
Singapore-based Clearbridge Medical Group (CBMG) opened its first centre in Hong Kong today (28 July 2017), riding on Hong Kong’s position as Asia’s medical hub in its regional expansion.
Associate Director-General of Investment Promotion Mr Charles Ng (right) and the Executive Director and Group CEO of Clearbridge Medical Group (CBMG), Mr Jeremy Yee, at the opening ceremony of CBMG’s first centre in Hong Kong.
The centre will offer patient care by deploying precision and data-driven medical technologies and bring in cutting-edge medical technologies, leveraging on strategic partnership with accredited laboratories and medical technology providers from overseas, including the US, Germany, Australia and Japan.
The first business to be launched in Hong Kong is its personalised lifestyle product – the metabolomics testing service aiming to promote and improve its clients’ lifestyle. Other products in the pipeline include molecular diagnostic testing services targeting the diagnostics of cancers in a non-invasive way such as the applications of liquid biopsy technologies.
The Executive Director and Group Chief Executive Officer, Mr Jeremy Yee said “Our wide access to medical centres across Asia in 11 countries and regions attracts a wide range of med-tech and service innovators in the healthcare, wellness and life science sectors. With our extended network of clinician-patient interaction points, Hong Kong is the perfect platform to deploy these advancements.”
Associate Director-General of Investment Promotion Mr Charles Ng said, “I would like to extend my warm welcome to CBMG’s new medical centre in Hong Kong. It will not only bring us innovative products, services and technologies in the healthcare sector but also add to the diversity of our biotech cluster.”
CBMG is under its parent company Clearbridge Health, a pan-Asia medical group that combines med-tech and healthcare innovations with powerful service delivery channels. CBMG ushers in a new, data-driven era of healthcare access in place of the traditional model of clinical chains and medical centres. For more information, please visit www.clearbridgehealth.com.
About Invest Hong Kong
Invest Hong Kong is the department of the Hong Kong Special Administrative Region Government established in 2000 to attract foreign direct investment and support overseas and Mainland businesses to set up or expand in Hong Kong. It provides free advice and customised services to help businesses succeed in Hong Kong’s vibrant economy. For more information, please visit www.investhk.gov.hk.
For an event photo, please visit www.flickr.com/photos/investhk/albums/72157686766314036.
Our partnership with the Hong Kong Polytechnic University, the government-driven initiative for tele‑medicine solutions and the eagerness of many medical facilities to become digital have enabled us to operate at the forefront of medical disruption.
Max von Waldenfels
Managing Director of Caspar Health